Apyx Medical Corp Proceeds from Stock Options Exercised
Apyx Medical Corp (APYX) reported Proceeds from Stock Options Exercised of $88.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06
- Apyx Medical Corp proceeds from stock options exercised for the quarter ending 2026-06-30 was $0.00.
- Apyx Medical Corp proceeds from stock options exercised for the quarter ending 2026-03-31 was $88.00K.
- Apyx Medical Corp proceeds from stock options exercised for the quarter ending 2025-12-31 was $439.00K.
- Apyx Medical Corp proceeds from stock options exercised for the quarter ending 2025-09-30 was $49.00K.
- Apyx Medical Corp proceeds from stock options exercised for fiscal 2025 was $488.00K.
- Apyx Medical Corp proceeds from stock options exercised for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Apyx Medical Corp proceeds from stock options exercised for fiscal 2023 was $86.00K, a 76.44% decline from fiscal 2022.
- Apyx Medical Corp proceeds from stock options exercised for fiscal 2022 was $365.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $88.00K 10-Q · filed 2026-08-06 | $527.00K derived: sum of 3 quarters · filed 2026-08-06 | $576.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $88.00K 10-Q · filed 2026-05-07 | $527.00K derived: sum of 2 quarters · filed 2026-05-07 | $576.00K derived: sum of 3 quarters · filed 2026-05-07 | $576.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $488.00K derived: sum of 2 quarters · filed 2026-03-10 | $488.00K derived: sum of 3 quarters · filed 2026-08-06 | $488.00K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $49.00K derived: sum of 2 quarters · filed 2026-08-06 | $49.00K 10-Q · filed 2025-11-06 | $49.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $86.00K 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $86.00K 10-Q · filed 2024-11-08 | ||||
| 2022-12-31 | $365.00K 10-K · filed 2024-03-21 | ||||
| 2018-12-31 | $202.57K 10-K · filed 2019-03-14 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 | ||||
| 2016-12-31 | -$106.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $12.30K 10-K · filed 2019-03-14 | |||
| 2016-09-30 | $119.00K 10-Q · filed 2016-10-27 | ||||
| 2015-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$1.26M derived: sum of 2 quarters · filed 2018-03-13 | $32.25K derived: sum of 3 quarters · filed 2018-03-13 | $209.25K 10-K · filed 2018-03-13 | $1.43M 10-K · filed 2016-03-18 |
| 2015-09-30 | -$39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $1.25M derived: sum of 2 quarters · filed 2016-10-27 | $1.43M 10-Q · filed 2016-10-27 | $1.27M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $1.47M 10-Q · filed 2016-08-02 | $1.30M derived: sum of 3 quarters · filed 2017-03-10 | $1.38M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-03-31 | $177.00K 10-Q · filed 2016-05-11 | $15.47K derived: sum of 2 quarters · filed 2017-03-10 | $93.47K derived: sum of 3 quarters · filed 2017-03-10 | ||
| 2014-12-31 | -$161.53K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$83.53K derived: sum of 2 quarters · filed 2017-03-10 | $87.47K 10-K · filed 2017-03-10 | $259.00K 10-K · filed 2015-02-27 | |
| 2014-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $249.00K 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $171.00K 10-Q · filed 2015-08-07 | ||||
| 2013-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-18 | $7.02M derived: sum of 2 quarters · filed 2016-03-18 | $7.03M derived: sum of 3 quarters · filed 2016-03-18 | $7.05M 10-K · filed 2016-03-18 | |
| 2013-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $30.00K derived: sum of 2 quarters · filed 2014-11-10 | $48.00K 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $24.00K 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $18.00K 10-Q · filed 2014-05-15 | ||||
| 2012-12-31 | $0.00 10-K · filed 2013-04-01 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | ||||
| 2011-12-31 | $0.00 10-K · filed 2013-04-01 | ||||
| 2010-12-31 | $9.00K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |